secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001213900-24-083408
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics raises $5M in private placement of pre-funded warrants and Series A/B warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$5M; net proceeds ~$4.5M after fees and expenses.
- Issued 1,219,513 pre-funded warrants at $0.001 exercise, plus Series A and B warrants at $3.85 exercise; combined price $4.099 per unit.
- Series A warrants expire in 5 years, Series B warrants expire in 18 months.
- Proceeds for working capital and general corporate purposes; H.C. Wainwright acted as placement agent.
- Company agreed to file resale registration statement within 15 days; 90-day lock-up on further equity issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/0001213900-24-083408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/ea0215863-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-083408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer